Kodiak Sciences (KOD) News
NASDAQ: KODHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
99.87+5.61 (+5.95%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
KOD news summary
We found 2 recent headlines mentioning Kodiak Sciences (KOD): 0 in the past week and 1 in the past 30 days, most often from Nasdaq. KOD is making an outsized move today, up 5.95% at $99.87, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "KOD Stock Soars 178% on Positive Wet AMD Data as BLA Filing Nears", was published by Nasdaq on Sep 29, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Kodiak Sciences headlines
- KOD Stock Soars 178% on Positive Wet AMD Data as BLA Filing NearsKodiak surges 178% as positive phase III DAYBREAK data show Zenkuda and tabirafusp-ted met key endpoints against Eylea.NasdaqKOD, REGN, ACIU, PGEN
- Kymera Appoints Felix Baker As Board Chairman, Succeeds Bruce Booth(RTTNews) - Kymera Therapeutics, Inc. (KYMR), a clinical-stage biopharmaceutical company, announced the appointment of Felix J. Baker as Chairman of the Board of Directors. He succeeds Bruce Booth,…NasdaqBCYC, KNSA, KOD, KYMR